Hot Pursuit     07-Jun-24
Biocon Ltd spurts 1.22%, gains for third straight session
Biocon Ltd is quoting at Rs 336.8, up 1.22% on the day as on 12:49 IST on the NSE. The stock is up 39.43% in last one year as compared to a 24.64% gain in NIFTY and a 51.19% gain in the Nifty Pharma index.

Biocon Ltd is up for a third straight session in a row. The stock is quoting at Rs 336.8, up 1.22% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.78% on the day, quoting at 23226.9. The Sensex is at 76478.93, up 1.87%. Biocon Ltd has added around 9.71% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has added around 3.55% in last one month and is currently quoting at 19232.1, up 1.5% on the day. The volume in the stock stood at 107.76 lakh shares today, compared to the daily average of 101.91 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 337.3, up 0.9% on the day. Biocon Ltd is up 39.43% in last one year as compared to a 24.64% gain in NIFTY and a 51.19% gain in the Nifty Pharma index.

The PE of the stock is 369.61 based on TTM earnings ending March 24.

Previous News
  Indices trade with decent gains; realty shares rallied for 5th day
 ( Market Commentary - Mid-Session 17-May-24   12:40 )
  Biocon Ltd spurts 1.11%, gains for five straight sessions
 ( Hot Pursuit - 24-Aug-23   13:01 )
  Biocon's subsidiary receives UK’s MHRA approval for Aflibercept biosimilar
 ( Hot Pursuit - 13-Nov-23   17:05 )
  Biocon Biologics refinances debt through USD bonds and syndicated term loan
 ( Corporate News - 03-Oct-24   09:29 )
  Biocon AGM scheduled
 ( Corporate News - 17-May-24   13:47 )
  Biocon Biologics receives UDFDA approval for Yesafili™
 ( Corporate News - 21-May-24   09:13 )
  Biocon gets US FDA approval for market generic version of anti-cancer drug
 ( Hot Pursuit - 07-Feb-24   09:35 )
  Biocon appoints director
 ( Corporate News - 12-Dec-22   19:04 )
  Biocon's Bangalore-based API facility gets GMP certificate from German authority
 ( Hot Pursuit - 09-Jun-23   09:24 )
  Biocon partners with Zentiva for commercialization of Liraglutide in Europe
 ( Corporate News - 24-Nov-22   09:51 )
  Biocon reports consolidated net loss of Rs 41.80 crore in the December 2022 quarter
 ( Results - Announcements 15-Feb-23   07:55 )
Other Stories
  Vipul Organics hits record high after receiving consent to establish for Ambernath facility
  03-Oct-24   15:31
  Surana Solar jumps 51% in ten days
  03-Oct-24   15:24
  CARE Ratings reaffirms 'A+' rating of Spandana Sphoorty with 'stable' outlook
  03-Oct-24   15:22
  Adani Green arm inks pact to supply green power to C&I customer
  03-Oct-24   15:01
  Sobha Ltd Partly Paidup leads losers in 'A' group
  03-Oct-24   15:00
  Auro Pharma gets USFDA nod for urinary tract infections drug.
  03-Oct-24   14:58
  Jubilant Ingrevia hits 52-week high after arm inks pact with Agrochemical company
  03-Oct-24   14:55
  Palash Securities Ltd leads losers in 'B' group
  03-Oct-24   14:45
  RITES inks MOU with DMRC for exploring Metro works
  03-Oct-24   14:35
  Volumes spurt at Jubilant Ingrevia Ltd counter
  03-Oct-24   14:30
Back Top